Letter to the editor: Botulinum type A treatment: no evidence of increased risk of seizures in juvenile cerebral palsy

Abstract

Get full access to this article

View all access options for this article.

References

Albavera-Hernandez C. , Rodriguez JM , Idrovo AJ Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil 2009; 23: 394-407.

Idrovo AJ , Albavera-Hernandez C. , Rodriguez JM Letter to the editor on ‘Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials’. Clin Rehabil 2009; 23: 862-63.

Graham HK , Boyd R. , Carlin JB et al. Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and ‘hips at risk’? A randomized, controlled trial. J Bone Joint Surg Am 2008 ; 90: 23-33.

Russo RN , Crotty M. , Miller MD , Murchland S. , Flett P. , Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics 2007 ; 119: e1149-e1158.

Lowe K. , Novak I. , Cusick A. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. Dev Med Child Neurol 2007; 49: 823-29.

Lowe K. , Novak I. , Cusick A. Low-dose/high concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2006; 48: 170-5.

Baker R. , Jasinski M. , Maciag-Tymecka I. et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002; 44: 666-75.

Ubhi T. , Bhakta BB , Ives HL , Allgar V. , Roussounis SH Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481-87.

Moore AP , de-Hall RA , Smith CT et al. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. Neurology 2008 ; 71: 122-28.

10.

Albavera-Hernández C. , Rodríguez JM , Idrovo AJ Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil 2009; 23: 394-407.

11.

Brin MF , Pogoda JN , Boodhoo T. , Bowen B. Botulinum toxin type A treatment does not increase the risk of seizures in juvenile cerebral palsy (Reply to Albavera-Hernandez et al. , Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials) . Clin Rehabil (in press).